Targeted therapies for high-risk cancer – a reason for hope?

15 April, 12:30pm - 1:30pm

Targeted therapies for high-risk cancers use drugs or substances to specifically attack cancer cells or environments based on their genetic mutations, minimising damage to healthy cells. These therapies may offer a more personalised and effective treatment approach. 

The seminar will feature presentations from Prof Minoti Apte (UNSW Sydney and Ingham Institute), Prof David Ziegler (Children’s Cancer Institute), and A/Prof Tara Roberts (Western Sydney University and Ingham Institute). This session will be chaired by Prof Hubert Hondermarck (University of Newcastle).

Join us for an insightful session where leading experts will discuss the latest advancements in targeting specific high-risk cancers. This seminar aims to enhance understanding and foster collaboration in cancer research.

Speakers:
Professor Minoti Apte, Professor of Medicine and Director of Research Strategy at the South Western Sydney Campus, UNSW Sydney and The Ingham Institute for Applied Medical Research
Professor David Ziegler, Paediatric Oncologist at the Kids Cancer Centre and Group Leader for Brain Tumours Group at the Children's Cancer Institute 
Associate Professor Tara Roberts, Oncology Researcher and Lead for Cancer and Inflammation Lab, Western Sydney University and The Ingham Institute for Applied Medical Research.

Session Chair: 
Professor Hubert Hondermarck, Head of the Cancer Neuroscience Laboratory, University of Newcastle  

Register here